P. Harper

发表

Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung.

R. Souhami, D. Geddes, I. Bradbury, 1985, Cancer research.

The pharmacokinetics of ifosfamide given as short and long intravenous infusions in cancer patients.

N. Thatcher, L. Lewis, P. Harper, 1991, British journal of clinical pharmacology.

Fractionated ifosfamide therapy produces a time-dependent increase in ifosfamide metabolism.

L. Lewis, P. Harper, H. Rogers, 1990, British journal of clinical pharmacology.

Rational Categorization of the Pipeline of New Treatments for Advanced Cancer – Prostate Cancer as an Example

S. Rudman, C. Sweeney, P. Harper, 2013 .

Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials

R. Schilsky, J. Marshall, P. Rougier, 2004, British Journal of Cancer.

Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse

R. Huddart, S. Hain, M. O'Doherty, 2000, British Journal of Cancer.

Nanoparticle albumin-bound paclitaxel for metastatic breast cancer.

P. Ellis, M. Harries, P. Harper, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical pharmacokinetics of epirubicin: the importance of liver biochemistry tests.

N. Dobbs, C. Twelves, R. Rubens, 1992, British Journal of Cancer.

Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patients

B. Reigner, C. Poole, C. Twelves, 2002, Cancer Chemotherapy and Pharmacology.

Chemotherapy for the treatment of hormone‐refractory prostate cancer

S. Chowdhury, P. Harper, P. Harper, 2007, International journal of clinical practice.

A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. MRC Advanced Bladder Cancer Working Party.

M. Parmar, P. Clark, G. Griffiths, 1998, British Journal of Cancer.

Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer.

J. Douillard, P. Hoff, B. Lembersky, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The response of cerebral metastases in small cell lung cancer to systemic chemotherapy.

H. Earl, R. Souhami, D. Geddes, 1990, British Journal of Cancer.

Vinorelbine (Navelbine) in the treatment of non-small-cell lung cancer: studies with single-agent therapy and in combination with cisplatin.

R. Gralla, S. Johnson, P. Harper, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Immunomodulation therapy in colorectal carcinoma.

C. Karapetis, D. Yip, P. Harper, 2000, Cancer treatment reviews.

THE TREATMENT OF METASTATIC COLORECTAL CANCER

C. Karapetis, D. Yip, P. Harper, 1999, International journal of clinical practice.

Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients.

D. Bailey, C. Steer, P. Harper, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

The management of PS2 patients with advanced non‐small cell lung cancer

P. Harper, P. Harper, K. Cheong, 2006, International journal of clinical practice.

Quality of life and the treatment of advanced lung cancer.

P. Harper, T. Plunkett, K. Chrystal, 2003, Clinical lung cancer.

Symptomatic responses to neoadjuvant chemotherapy for carcinoma of the oesophagus and oesophagogastric junction: are they worth measuring?

J. Gossage, R. Mason, P. Harper, 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

A Randomized Study of Electronic Diary versus Paper and Pencil Collection of Patient-Reported Outcomes in Patients with Non-Small Cell Lung Cancer

David Cella, D. Cella, C. Watkins, 2008, The patient.

Anticancer evidence for zoledronic acid across the cancer continuum.

R. Coleman, A. Lipton, P. Harper, 2011, Critical reviews in oncology/hematology.

Management of the elderly patient with advanced  non‐small cell lung cancer

P. Harper, P. Harper, K. Cheong, 2006, International journal of clinical practice.

O ral C apecitabine C ompared W ith I ntravenous Fluorouracil P lus L eucovorin i n P atients W ith M etastatic Colorectal C ancer: R esults o f a L arge P hase I II S tudy

P. Rougier, W. Schmiegel, C. Weitzel, 2001 .

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.

E. Van Cutsem, P. Rougier, W. Schmiegel, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II trial of continuous 5-fluorouracil in recurrent or metastatic transitional cell carcinoma of the urinary tract.

M. Parmar, R. Huddart, M. Highley, 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

Oral versus intravenous fluoropyrimidines for metastatic colorectal cancer.

C. Steer, C. Karapetis, D. Yip, 2016 .

A dose-escalating study of oral eniluracil/5-fluorouracil plus oxaliplatin in patients with advanced gastrointestinal malignancies.

C. Steer, C. Karapetis, D. Yip, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Original Paper 'Tomudex' (ZD1694): Results ofa Randomised Trial in Advanced Colorectal Cancer Demonstrate Efficacy and Reduced Mucositis and Leucopenia

D. Kerr, D. Cunningham, I. Olver, 1995 .

'Tomudex' (ZD1694): results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. The 'Tomudex' Colorectal Cancer Study Group.

D. Kerr, E. Van Cutsem, J. Zalcberg, 1995, European journal of cancer.

Volunteers or victims: patients' views of randomised cancer clinical trials.

A. Bowling, M. Slevin, N. Thatcher, 1995, British Journal of Cancer.

Incidence of pulmonary nodules detected by computed tomography in patients with bronchial carcinoma.

R. Souhami, D. Mitchell, S. Spiro, 1986, Clinical radiology.

Current clinical practices for ovarian cancers.

P. Harper, 2002, Seminars in oncology.

Computerized axial tomography in the pretreatment assessment of small‐cell carcinoma of the bronchus

M. Hodson, R. Souhami, S. Spiro, 1981, Cancer.

Patients at risk of chemotherapy-associated toxicity in small cell lung cancer.

H. Earl, R. Souhami, S. Spiro, 1989, British Journal of Cancer.

Staging classification committee.

J. Jett, R. Ginsberg, R. Tsuchiya, 1997, Lung cancer.

Lung cancer: future prospects.

R. Souhami, S. Spiro, D. Geddes, 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

O-69 A randomized study of timing of thoracic irradiation in small cell lung cancer (SCLC) — study 8

R. Rudd, S. Wan, N. Gower, 2003 .

Staging of small cell lung cancer

P. Harper, 1985 .

Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.

A. Hackshaw, R. Rudd, N. Gower, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy of small cell lung cancer: state of the art

P. Harper, K. Cheong, K. Chrystal, 2004, Current opinion in oncology.

Computed tomography of the thorax in the diagnosis and management of malignant disease.

R. Souhami, S. Spiro, D. Geddes, 1982, British journal of diseases of the chest.

Phase II trial of idarubicin in patients with advanced lymphoma

S. Johnson, P. Harper, H. Rogers, 2004, Cancer Chemotherapy and Pharmacology.

A dose escalation study of carboplatin and ifosfamide in advanced ovarian cancer

R. Coleman, E. Wiltshaw, P. Harper, 2004, Cancer Chemotherapy and Pharmacology.

A phase II study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervix

M. Slevin, R. Coleman, J. Sweetenham, 2004, Cancer Chemotherapy and Pharmacology.

Mitomycin, ifosfamide and cisplatin in non-small-cell lung cancer

H. Earl, R. Souhami, D. Miles, 2004, Cancer Chemotherapy and Pharmacology.

A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix

R. Souhami, M. Slevin, R. Coleman, 2004, Cancer Chemotherapy and Pharmacology.

The response of cerebral metastases in small cell lung cancer to systemic chemotherapy.

H. Earl, R. Souhami, D. Geddes, 1990, British Journal of Cancer.

Combination therapy versus single agent chemotherapy in non-small cell lung cancer

J. Spicer, S. Chowdhury, P. Harper, 2005, Expert opinion on pharmacotherapy.

Bisphosphonate Use in Patients with Lung Cancer and Bone Metastases: Recommendations of a European Expert Panel

K. Nackaerts, F. de Marinis, K. Syrigos, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Chemotherapy for ovarian cancer--a consensus statement on standard practice.

H. Earl, M. Gore, G. Jayson, 1998, British Journal of Cancer.

Amplification of epidermal growth factor receptor gene in renal cell carcinoma.

A. Ravaud, J. Machiels, C. Sternberg, 2010, European journal of cancer.

Aims and difficulties of targeting

S. Chowdhury, P. Harper, 2006, Targeted Oncology.

PET and PLAP in suspected testicular cancer relapse: beware sarcoidosis.

J. D. van der Walt, C. Karapetis, D. Yip, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Symptoms and quality of life: important patient outcomes?

P. Harper, 2003 .

Unexpected serious toxicity with chemotherapy and antiangiogenic combinations: time to take stock!

N. Pavlakis, D. Khayat, C. Steer, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of life: it's never too late.

D. Khayat, C. Steer, P. Harper, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Palliative Treatment: What’s the Point?

A. Ring, P. Harper, 2002, American journal of clinical oncology.

A phase I and II trial of epirubicin, cisplatin, 24‐hour infusion 5 fluorouracil and sodium folinate in patients with advanced esophagogastric carcinomas

C. Steer, C. Karapetis, D. Yip, 2010, Asia-Pacific journal of clinical oncology.

KAPOSI'S SARCOMA ASSOCIATED WITH AIDS IN A WOMAN FROM UGANDA

P. Harper, D. Edwards, A. K. Pain, 1984, The Lancet.

Targeted therapy in hormone refractory prostate cancer

S. Chowdhury, P. Harper, S. Burbridge, 2007, Targeted Oncology.

Advanced epithelial ovarian cancer: 1998 consensus statements.

M. Parmar, E. Eisenhauer, M. Gore, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study.

C. Steer, D. Yip, P. Harper, 2006, Gynecologic oncology.

Letter to the Editor

V. Torri, N. Colombo, A. Swart, 2004, International Journal of Gynecologic Cancer.

Multicenter phase II study of gemcitabine in previously untreated patients with advanced epithelial ovarian cancer

M. Highley, F. Hirsch, J. Carmichael, 2001, Anti-cancer drugs.

The role of anthracyclines in epithelial ovarian cancer.

M. Buyse, J. Vermorken, P. Harper, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Intergroup collaboration in ovarian cancer: a giant step forward

M. Piccart, M. Parmar, E. Eisenhauer, 1999 .

Effect of cancer chemotherapy on dapsone N-acetylation in man

P. Philip, P. Harper, H. Rogers, 2004, Cancer Chemotherapy and Pharmacology.

Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial.

R. Souhami, I. Bradbury, F. Fearon, 1984, British medical journal.

Treatment of nondysgerminomatous ovarian germ cell tumors

A. Horwich, M. Gore, C. Fisher, 1999, Cancer.

Decreased plasma half-life of cyclophosphamide during repeated high-dose administration

R. Souhami, R. Souhami, A. Mclean, 2004, Cancer Chemotherapy and Pharmacology.

Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: single‐centre experience with long‐term follow up *

C. Steer, C. Karapetis, D. Yip, 2003, Internal medicine journal.

The relationship between vitamin D and chemotherapy-induced toxicity – a pilot study

P. Ellis, P. Harper, J. Stebbing, 2012, British Journal of Cancer.

Is repeated flushing of Hickman catheters necessary?

C. Rudge, P. Harper, H. Gillies, 1985, British medical journal.

The small intestine in dermatitis herpetiformis

P. Harper, L. Fry, A. V. Hoffbrand, 1974, Journal of clinical pathology.

Uroepithelial and nephrotubula toxicity in patients receiving ifosfamide/mesna: Measurement of urinary N-acetyl-β-d-glucosaminidase and β-2-microglobulin

L. Lewis, P. Harper, H. Rogers, 1992 .

Intensive chemotherapy with autologous bone marrow transplantation in small cell carcinoma of the lung.

R. Souhami, P. Harper, 1985, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodol.

N. Dobbs, Roger Williams, P. Harper, 1991, Journal of hepatology.

Pretreatment minimal staging for non-small cell lung cancers: a consensus report

U. Pastorino, R. Stahel, A. Turrisi, 1991 .

Influenza vaccination and chemotherapy: a shot in the dark?

C. Steer, A. Ring, P. Harper, 2002, Supportive Care in Cancer.

Pharmacokinetics of idarubicin (4-demethoxydaunorubicin; IMI-30; NSC 256439) following intravenous and oral administration in patients with advanced cancer.

P. Harper, H. Rogers, K. Ohashi, 1987, British journal of clinical pharmacology.

Assessing anaemia and fatigue:putting theory into practice

P. Harper, J. Morère, 2006 .

Recent progress in improving quality of life in cancer patients

P. Harper, 2000, International Journal of Pharmaceutical Medicine.

Anaemia of Cancer: Impact on Patient Fatigue and Long-Term Outcome

T. Littlewood, P. Harper, 2005, Oncology.

Advanced epithelial ovarian cancer

M. Parmar, E. Eisenhauer, M. Gore, 1999 .

What is the best treatment for early operable small cell carcinoma of the bronchus?

R. Souhami, S. Spiro, D. Geddes, 1981, Thorax.

Results of a randomised trial comparing ECF with MCF in advanced oesophago-gastric cancer

T. Hickish, A. Norman, M. Nicolson, 1999 .

Castration Refractory Prostate Cancer: Cinderella Finally Comes to the Ball

T. Powles, S. Chowdhury, P. Harper, 2010, Oncology Research and Treatment.

A randomised double-blind placebo controlled clinical trial assessing the tolerability and efficacy of glutathione as an adjuvant to escalating doses of cisplatin in the treatment of advanced ovarian cancer.

D. Pickering, R. Coleman, C. Topham, 1995, European journal of cancer.

A comparision of two devices for the continuous infusion of cytotoxic drugs in non‐hospitalised patients

P. Harper, M. Summerhayes, Z. Fisher, 1991 .

The role of cytoreductive nephrectomy for renal cell carcinoma in the era of targeted therapy

T. Choueiri, S. Chowdhury, P. Harper, 2008, Nature Clinical Practice Oncology.

Social consequences of brain or liver relapse in small cell carcinoma of the bronchus.

R. Souhami, S. Spiro, D. Geddes, 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Integration of new or experimental treatment options and new approaches to clinical trials.

E. Trimble, M. Quinn, S. Grénman, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiation‐induced lung fibrosis after treatment of small cell carcinoma of the lung with very high‐dose cyclophosphamide

R. Souhami, D. Geddes, S. Spiro, 1985, Cancer.

Chemotherapy for Uterine Cancer

P. Harper, K. Cheong, K. Chrystal, 2005 .

Tumor size, response rate, and prognosis in small cell carcinoma of the bronchus treated by combination chemotherapy.

R. Souhami, J. Smyth, F. Fearon, 1982, Cancer treatment reports.

High-dose folinic acid with 5-fluorouracil bolus and continuous infusion in the treatment of advanced gastric and oesophageal adenocarcinoma.

M. Highley, R. Mason, P. Harper, 1993, British Journal of Cancer.

PHASE III RANDOMISED COMPARISON OF GEMCITABINE (GEM) WITH GEMCITABINE PLUS CAPECITABINE (GEM-CAP) IN PATIENTS WITH ADVANCED PANCREATIC CANCER

J. Neoptolemos, D. Stocken, J. Dunn, 2005 .

Which 5-fluorouracil regimen?--the great debate.

R. Labianca, M. Vincent, P. Harper, 1999, Anti-cancer drugs.

Chemotherapy for poor risk germ cell tumours. An independent evaluation of the POMB/ACE regime.

M. Cullen, P. Harper, P. Kirkbride, 1988, British journal of urology.

Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancer

H. Earl, R. Souhami, D. Geddes, 2004, Cancer Chemotherapy and Pharmacology.

High-dose cyclophosphamide in small-cell carcinoma of the lung.

R. Souhami, W. Gregory, R. Buckman, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term follow-up of Anglian Germ Cell Cancer Group surveillance versus patients with Stage 1 nonseminoma treated with adjuvant chemotherapy.

M. Williams, D. Neal, J. Shamash, 2004, Urology.

Chemotherapy in small cell lung cancer: a consensus report

M. Fukuoka, P. Bunn, H. Hansen, 1989 .

The optimal hemoglobin level in the cancer patient.

P. Harper, M. Dicato, 2002, Seminars in oncology.

Cisplatin and carboplatin in combination for the treatment of stage IV ovarian carcinoma.

M. Slevin, T. Perren, E. Wiltshaw, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

THROMBOEMBOLIC EVENTS DURING COMBINATION CHEMOTHERAPY FOR GERM CELL MALIGNANCY

M. Richards, P. Harper, M. Hall, 1988, The Lancet.

Chemotherapy and radiotherapy for pancreatic cancer

D. Goldstein, C. Steer, C. Karapetis, 2000 .

Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: a Cancer Research Campaign trial.

R. Souhami, M. Partridge, R. Rudd, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial

R. Eeles, H. Kitchener, M. Gore, 2016 .

A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial

R. Huddart, G. Rustin, G. Mead, 2005, British Journal of Cancer.

Is there any place for cytotoxic chemotherapy in endometrial cancer?

C. Steer, P. Harper, 2001, Best practice & research. Clinical obstetrics & gynaecology.

Intergroup collaboration in ovarian cancer: a giant step forward.

M. Piccart, M. Parmar, E. Eisenhauer, 1999, Annals of Oncology.

Bone metastases in germ cell tumours: lessons learnt from a large retrospective study

T. Powles, J. Shamash, M. Jamal-Hanjani, 2013, BJU international.

Phase I II C omparative S tudy o f H igh-Dose C isplatin Versus a C ombination o f P aclitaxel a nd C isplatin i n Patients W ith A dvanced N on-Small-Cell L ung C ancer

J. Bogaerts, U. Gatzemeier, K. Mattson, 2000 .

Neoadjuvant chemotherapy for locally advanced carcinoma of the lower oesophagus and oesophago-gastric junction.

J. Gossage, S. Atkinson, A. Botha, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Treatment of invasive thymoma with single-agent ifosfamide.

M. Highley, C. Karapetis, B. Bryant, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience

E. Sawyer, S. Johnston, R. Roylance, 2019, Breast Cancer Research and Treatment.

Induction therapy for stage III NSCLC: a consensus report.

R. Ginsberg, M. Fukuoka, A. Ardizzoni, 1994, Lung cancer.

Haematological recovery following high-dose cyclophosphamide with autologous bone marrow transplantation

C. Twelves, A. Goldstone, P. Harper, 2004, Cancer Chemotherapy and Pharmacology.

mic patients withhepatocellular carcinoma: relation to liver tests andpharmacokinetic parameters

N. Dobbs, P. Johnson, R. Williams, 1992 .

Comparative pharmacokinetics of doxorubicin given by three different schedules with equal dose intensity in patients with breast cancer

N. Dobbs, C. Twelves, R. Rubens, 1991, Cancer Chemotherapy and Pharmacology.

Early closure of a randomized controlled trial of three treatment approaches to early localised prostate cancer: the MRC PR06 trial

Srinivasan, P. Fayers, M. Sydes, 2004, BJU international.

Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancer.

H. Earl, R. Souhami, D. Miles, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Received dose-intensity: a randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer.

R. Souhami, J. Ledermann, W. Gregory, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Position paper by the UKCCCR Elderly Cancer Patients in Clinical Trials Working Group

L. Fallowfield, I. Fentiman, E. Grundy, 1999, British Journal of Cancer.

Clinical Investigation of the Role of Interleukin-4 and Interleukin-13 in the Evolution of Prostate Cancer

S. Chowdhury, J. Maher, A. Chandra, 2011, Cancers.

Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis

J. Larkin, L. Pickering, M. Gore, 2011, BJU international.

The antiemetic efficacy and safety of granisetron compared with metoclopramide plus dexamethasone in patients receiving fractionated chemotherapy over 5 days

V. Diehl, D. Dearnaley, H. Keizer, 1993, Journal of Cancer Research and Clinical Oncology.

Self-expanding metallic stents in the management of pyloric dysfunction after gastric pull-up operations

P. Harper, M. Cowling, R. Mason, 1999, European Radiology.

E06-02: Update on bone metastases and biomarkers in non-small cell lung cancer

P. Harper, 2007 .

Percutaneous insertion of tunnelled central venous catheters is a safe out-patient procedure

P. Harper, J. Reidy, P. Harper, 2000 .

Thymidylate Synthase Inhibitors, Modulation of 5-Fluorouracil and Folate Analogues

H. Calvert, P. Harper, 1994 .

Pseudomyxoma peritonei: the ‘controversial’ disease

C. Steer, P. Harper, E. Galani, 2003, International Journal of Gynecologic Cancer.

A Brief Report on the Safety Study of Induction Chemotherapy Followed by Synchronous Radiotherapy and Cetuximab in Stage III Non-small Cell Lung Cancer (NSCLC): SCRATCH Study

J. Shamash, D. Landau, S. Hughes, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Combined modality treatments in early non-small cell lung cancer.

P. Harper, G. Marx, 2002, Lung cancer.

Phase II study of BAY 73-4506, a multikinase inhibitor, in previously untreated patients with metastatic or unresectable renal cell cancer.

T. Eisen, H. Joensuu, P. Nathan, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carboplatin and ifosfamide in ovarian cancer phase II and III trials

M. Slevin, T. Perren, E. Wiltshaw, 2004, Cancer Chemotherapy and Pharmacology.

Small-cell lung cancer, high growth rate, high response rate to chemotherapy: ideal for high-dose chemotherapy?

P. Ellis, P. Harper, E. Galani, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

COMPUTERIZED AXIAL TOMOGRAPHY IN THE PRETREATMENT ASSESSMENT OF SMALL-CELL CARCINOMA OF THE BRONCHUS

M. Hodson, D. Geddes, P. Harper, 1981 .

Avascular necrosis of bone caused by combination chemotherapy without corticosteroids.

R. Souhami, P. Harper, C. Trask, 1984, British medical journal.

Coexistence of acanthosis nigricans and the sign of Leser-Trélat in a patient with gastric adenocarcinoma: a case report and literature review.

P. Harper, S. Munn, P. Harper, 2000, Journal of the American Academy of Dermatology.

Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1‐mm thick)

G. Auclerc, C. Soubrane, D. Khayat, 2003, Cancer.

Management of Merkel cell carcinoma

P. Harper, T. Plunkett, M. Leslie, 2001, Expert review of anticancer therapy.

Gastroesophageal cancer, palmar fasciitis and a matrix metalloproteinase inhibitor

P. Harper, K. Lynch, K. Virik, 2002, Internal medicine journal.

Treatment of obstruction of the superior vena cava by combination chemotherapy with and without irradiation in small-cell carcinoma of the bronchus.

R. Souhami, S. Spiro, D. Geddes, 1983, Thorax.

Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials

T. Hickish, A. Norman, J. Black, 2006, British Journal of Cancer.

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.

D. Alberts, R. Burger, E. Trimble, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials.

T. Hickish, A. Norman, M. Nicolson, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil in the treatment of carcinoma of unknown primary site

P. Harper, C. Karapetis, K. Ryder, 2001, Medical oncology.

Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial.

William Berry, Oliver Sartor, J Alfred Witjes, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group.

M. Piccart, M. Nooij, M. Franchi, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

T. Hickish, A. Norman, M. Nicolson, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

5‐FLUOROURACIL‐INDUCED ERYTHEMA MULTIFORME

D. Yip, P. Harper, M. Leslie, 1999, International journal of clinical practice.

2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).

E. Trimble, M. Parmar, E. Eisenhauer, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

High-dose ifosfamide by infusion with mesna in advanced soft tissue sarcoma.

S. Kaye, R. Stuart-Harris, E. Wiltshaw, 1983, Cancer treatment reviews.

Targeted therapies for non‐small cell lung cancer

J. Spicer, P. Harper, P. Harper, 2005, International journal of clinical practice.

Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trial.

Frank Pétavy, Jean-Pascal Machiels, Patrick Schöffski, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study.

M. Slevin, R. Coleman, J. Sweetenham, 1991, British Journal of Cancer.

Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer.

W. Scheithauer, C. Tudur-Smith, R. Herrmann, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Spinal cord compression in small cell lung cancer: a retrospective study of 610 patients.

R. Souhami, S. Spiro, C. M. Ash, 1989, British Journal of Cancer.

Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancer.

J. Bogaerts, F. de Marinis, J. von Pawel, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pancreatic cancer treatment and research: an international expert panel discussion.

J. Berlin, E. Van Cutsem, M. Ducreux, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic factors in non-small cell lung cancer.

R. Ginsberg, R. Arriagada, M. Paesmans, 1991, Lung cancer.

L. Fallowfield, P. Harper, 2005, Lung cancer.

Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. London Gynaecological Oncology Group.

M. Gore, M. Slevin, R. A’Hern, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Multicenter Phase I Gene Therapy Clinical Trial Involving Intraperitoneal Administration of E1A-Lipid Complex in Patients with Recurrent Epithelial Ovarian Cancer Overexpressing HER-2/neu Oncogene

M. Gore, T. Ganesan, R. Lechler, 2004, Clinical Cancer Research.

High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma

S. Kaye, R. Stuart-Harris, C. Parsons, 2004, Cancer Chemotherapy and Pharmacology.

A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. The London Gynaecologic Oncology Group.

M. Gore, M. Slevin, R. Stein, 1993, British Journal of Cancer.

A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma

P. Lorigan, N. Thatcher, M. Middleton, 2000, British Journal of Cancer.

Matrix Metalloproteinase Inhibitors: Applications in Oncology

C. Karapetis, D. Yip, P. Harper, 2004, Investigational New Drugs.

Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial.

R. Eeles, H. Kitchener, M. Gore, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Cancer Research Campaign (CRC) phase II trial of CB10-277 given by 24 hour infusion for malignant melanoma.

N. Bleehen, S. Kaye, P. Harper, 1994, British Journal of Cancer.

Influence of dexamethasone dose on the control of chemotherapy-induced nausea and vomiting.

C. Twelves, R. Rubens, R. Coleman, 1991, European journal of cancer.

Sentinel node biopsy: an in depth appraisal.

C. Steer, P. Harper, N. Beechey-Newman, 2002, Critical reviews in oncology/hematology.

High-dose cyclophosphamide with autologous marrow transplantation as initial treatment of small cell carcinoma of the bronchus

R. Souhami, D. Geddes, D. Linch, 2004, Cancer Chemotherapy and Pharmacology.

Clinical efficacy and toxicity of standard dose adriamycin in hyperbilirubinaemic patients with hepatocellular carcinoma: relation to liver tests and pharmacokinetic parameters.

N. Dobbs, P. Johnson, R. Williams, 1992, British Journal of Cancer.

Phase II Study of Continuous Subcutaneous Interferon-Alfa Combined with Cisplatin in Advanced Malignant Melanoma

A. Harris, S. Fosså, A. Einstein, 1992 .

Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial.

Michael Jeffers, Heikki Joensuu, Tim Eisen, 2012, The Lancet. Oncology.

Phase II trial of temozolomide in low-grade non-Hodgkin's lymphoma.

D. Crowther, E. Newlands, P. Woll, 1995, British Journal of Cancer.

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

T. Hickish, A. Norman, M. Nicolson, 1999, British Journal of Cancer.

Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer.

T. Hickish, A. Norman, M. Nicolson, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial.

R. Souhami, D. Geddes, P. Harper, 1990, European journal of cancer.

Protracted oral etoposide in epithelial ovarian cancer: a phase II study in patients with relapsed or platinum-resistant disease.

M. Gore, M. Slevin, J. Mansi, 1994, British Journal of Cancer.

Avascular necrosis of bone: the hidden risk of glucocorticoids used as antiemetics in cancer chemotherapy.

C. Karapetis, P. Harper, K. Virik, 2001, International journal of clinical practice.

Comparison of vincristine and vindesine in the treatment of inoperable non-small cell bronchial carcinoma.

R. Souhami, S. Spiro, D. Geddes, 1983, Cancer treatment reports.

Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. "Tomudex" Colorectal Cancer Study Group.

D. Kerr, E. Van Cutsem, J. Zalcberg, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Acetylation and oxidation phenotypes in malignant lymphoma

P. Philip, P. Harper, H. Rogers, 2004, Cancer Chemotherapy and Pharmacology.

Phase II study of Edatrexate in stage III and IV non-small-cell lung cancer

R. Souhami, R. Rudd, S. Spiro, 2004, Cancer Chemotherapy and Pharmacology.

3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration.

E. Trimble, M. Parmar, E. Eisenhauer, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trials.

T. Hickish, A. Norman, M. Nicolson, 2006, European journal of cancer.

Presentation of Hodgkin's disease as an endobronchial lesion

R. Souhami, C. Fisher, P. Harper, 1984, Cancer.

Predictive and prognostic factors in small cell lung cancer: current status.

P. Harper, D. Yip, P. Harper, 2000, Lung cancer.

Hypertension and targeted therapy

J. Spicer, S. Chowdhury, P. Harper, 2006, Targeted Oncology.

Hypertension and targeted therapy

J. Spicer, S. Chowdhury, P. Harper, 2006, Targeted Oncology.

Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial.

M. Partridge, R. Souhami, M. Partridge, 1989, British Journal of Cancer.

A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer.

T. Hickish, A. Norman, D. Cunningham, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry

N. Dobbs, C. Twelves, R. Rubens, 2004, Cancer Chemotherapy and Pharmacology.

Epirubicin for pretreated advanced ovarian cancer.

R. Coombes, M. Slevin, R. Stein, 1990, European journal of cancer.

A phase II study of mitozantrone in advanced carcinoma of the ovary

M. Gore, M. Slevin, R. Coleman, 2004, Cancer Chemotherapy and Pharmacology.

Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity

C. Lewis, J. Sanderson, P. Ross, 2013, British Journal of Cancer.

WHO SHOULD TREAT CANCER?

P. Harper, J. Tobias, M. Tattersall, 1981, The Lancet.

A phase II study evaluating the tolerability and efficacy of CAELYX (liposomal doxorubicin, Doxil) in the treatment of unresectable pancreatic carcinoma.

S. Halford, C. Karapetis, D. Yip, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Albumin-Bound Paclitaxel In Metastatic Breast Cancer

M. Harries, P. Harper, 2006, Drugs.

Effects of treatment with rhEPO on quality of life in anemic cancer patients

P. Harper, S. Yip, 2002 .

Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council.

D. Kerr, R. Stephens, J. Ledermann, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial.

H. Earl, D. Geddes, R. Rudd, 1991, British Journal of Cancer.

Sequential chemotherapy in good-prognosis patients with small-cell lung cancer

R. Souhami, D. Geddes, C. Twelves, 2004, Cancer Chemotherapy and Pharmacology.

Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma (mRCC) with severe renal impairment or on haemodialysis.

J. Larkin, L. Pickering, T. Powles, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.

P. Harper, 1997, Seminars in oncology.

Efficacy of lapatinib in patients with high tumor EGFR expression: Results of a phase III trial in advanced renal cell carcinoma (RCC).

A. Ravaud, J. Machiels, H. von der Maase, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

969 Erythrocytes and the distribution of mitomycin C (MMC)

M. Highley, P. Harper, H. Lambrechts, 1995 .

Targeting novel and established therapies for non-small cell lung cancer.

J. Spicer, S. Chowdhury, P. Harper, 2007, Cancer letters.

Randomized phase III trial of gemcitabine/carboplatin with or without iniparib (BSI-201) in patients with previously untreated stage IV squamous non-small cell lung cancer (NSCLC).

M. Socinski, J. Hainsworth, T. Lynch, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer.

C. Redfern, J. Carmichael, D. Cunningham, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

High-dose cyclophosphamide with autologous marrow transplantation for small cell carcinoma of the bronchus

R. Souhami, D. Geddes, D. Linch, 2004, Cancer Chemotherapy and Pharmacology.

WHO SHOULD TREAT CANCER?

T. Lister, K. Calman, R. Buchanan, 1981, The Lancet.

The European Canadian Intergroup trial (OV10 trial) and the US Gynaecologic Oncology Group trial (GOG 111).

V. Torri, N. Colombo, A. Swart, 2004, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Gastro-oesophageal complications in patients receiving cancer therapy: the role of proton pump inhibitors.

C. Steer, P. Harper, 2002, European journal of gastroenterology & hepatology.

Update on gemcitabine/carboplatin in patients with advanced non-small cell lung cancer.

P. Harper, 2003, Seminars in oncology.

Reply to the letter “Limitations of bedside estimates of renal function”, by M. J. Dooley and S. G. Poole (doi:10.1093/annonc/mdi173)

C. Steer, P. Harper, G. Marx, 2005 .

Doxorubicin pharmacokinetics: the effect of abnormal liver biochemistry tests

N. Dobbs, C. Twelves, R. Rubens, 1998, Cancer Chemotherapy and Pharmacology.

Oral Capeci tabine Compared With Intravenous Fluorourac i l Plus Leucovor in in Pat ients With Metastat ic Colorecta l Cancer : Resul ts of a Large Phase III Study

P. Rougier, W. Schmiegel, C. Weitzel, 2001 .

Non-small cell lung cancer in the elderly.

P. Harper, E. Galani, P. Makrantonakis, 2004, The oncologist.

Quality trials and quality of life in non-small-cell lung cancer.

D. Khayat, P. Harper, T. Plunkett, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of rhEPO on quality of life in anemic cancer patients

J. Spicer, S. Chowdhury, P. Harper, 2008 .

Quality of life issues in metastatic patients

P. Harper, S. Yip, 2002 .

7141 POSTER Phase II Trial of the Oral Multikinase Inhibitor Regorafenib (BAY 73-4506) as First-line Therapy in Patients With Metastatic or Unresectable Renal Cell Carcinoma (RCC)

T. Eisen, H. Joensuu, P. Nathan, 2011 .

7105 Phase II trial of the oral multikinase inhibitor BAY 73–4506 as 1st-line therapy in patients with metastatic or unresectable renal cell cancer (RCC)

T. Eisen, H. Joensuu, P. Nathan, 2009 .

793 Five day oral etoposide treatment for advanced small cell lung cancer (SCLC): Quality of life (QOL) assessment in a randomised comparison with intravenous chemotherapy

R. Rudd, N. Gower, S. Spiro, 1997 .

Safety study of induction chemotherapy followed by Synchronous Radiotherapy (RT) and cetuximab in stage III non-small cell lung cancer (NSCLC): SCRATCH study (Cohort I): P2-184

J. Shamash, D. Landau, S. Rankin, 2007 .

The role of docetaxel (Taxotere) as a single agent or in combination before local treatment of non-small cell lung cancer.

P. Harper, 1997, Seminars in Oncology.

Rational Categorization of the Pipeline of New Treatments for Advanced Cancer – Prostate Cancer as an Example

S. Rudman, C. Sweeney, P. Harper, 2013 .

Bisphosphonate Use in Patients with Lung Cancer and Bone Metastases: Recommendations of a European Expert Panel

K. Nackaerts, F. de Marinis, K. Syrigos, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A phase I and II trial of epirubicin, cisplatin, 24‐hour infusion 5 fluorouracil and sodium folinate in patients with advanced esophagogastric carcinomas

C. Steer, C. Karapetis, D. Yip, 2010, Asia-Pacific journal of clinical oncology.

Non-platinum gemcitabine combinations in non-small cell lung cancer.

P. Harper, G. Marx, 2002, Lung cancer.

Identification of patients at high risk of chemotherapy-induced toxicity in small-cell lung cancer.

H. Earl, R. Souhami, D. Geddes, 1988, Antibiotics and chemotherapy.

A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial

R. Huddart, G. Rustin, G. Mead, 2005, British Journal of Cancer.

Very High Dose Chemotherapy with Autologous Bone Marrow Support in the Treatment of Small Cell Lung Cancer

F. Muggia, P. Harper, 1986 .

The effect of sunitinib on immune parameters and haemopoetic stem cell markers in patients with untreated clear cell renal cancer.

T. Powles, J. Shamash, S. Rudman, 2010 .